Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 141

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 141
---
 entered, enforced or applied to the Divestiture. |

In addition, the obligations of Kaken to complete the Divestiture are subject to the satisfaction or waiver (where permitted by applicable law) at or prior to the completion of the Divestiture of each of the following additional conditions, any of which may be waived exclusively by Kaken:

| • |     | the accuracy of certain of the representations and warranties of Aadi set forth in the Divestiture Agreement, as                                                                                                                                          
 of the date of the Divestiture Agreement and as of the completion of the Divestiture and, if applicable, such earlier date as of which such representation or warranty was specifically made, subject in each case to the materiality standards set forth 
 in the Divestiture Agreement;                                                                                                                                                                                                                             |

| • |     | Aadi and Aadi Sub having performed and complied in all material respects with all covenants, obligations and           
 conditions of the Divestiture Agreement required to be performed and complied by them on or prior to the closing date; |

| • |     | no Company Material Adverse Effect or Seller Material Adverse Effect having occurred since the date of the 
 Divestiture Agreement that is continuing;                                                                  |

| • |     | receipt by Kaken of a customary closing certificate of Aadi; and |

| • |     | the completion of the Pre-Closing Restructuring, including the receipt of                                                                                                                                                                       
 all required third-party consents, other than to the extent that the failure of such completion would not have a material adverse effect on Kaken or Aadi Sub’s ability to operate the FYARRO Business (see the section of this proxy statement 
 captioned “The Divestiture Agreement—The Pre-Closing Restructuring”), subject to materiality standards set forth in the Divestiture Agreement.                                                                                                  |

In addition, the obligations of Aadi to complete the Divestiture are subject to the satisfaction or waiver (where permitted by applicable law) at or prior to the completion of the Divestiture of each of the following additional conditions, any of which may be waived exclusively by Aadi:

| • |     | the accuracy of the representations and warranties of Kaken set forth in the Divestiture Agreement, as of the                                                                                                
 completion of the Divestiture and, if applicable, such earlier date as of which such representation or warranty was specifically made, in each case except for such failures (considered collectively) to be |

- 91 -

| true and correct that would not